🇯🇵 Novoeight in Japan

PMDA authorised Novoeight on 17 January 2014

Marketing authorisations

PMDA — authorised 17 January 2014

  • Marketing authorisation holder: Novo Nordisk Pharma Ltd.
  • Status: approved

Novoeight in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Rare Disease approved in Japan

Frequently asked questions

Is Novoeight approved in Japan?

Yes. PMDA authorised it on 17 January 2014; PMDA has authorised it.

Who is the marketing authorisation holder for Novoeight in Japan?

Novo Nordisk Pharma Ltd. holds the Japanese marketing authorisation.